Sichuan Kelun Pharmaceutical Hits Day Low Amid Price Pressure at CNY 44.90

Sichuan Kelun Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.84% and reaching an intraday low of CNY 44.90. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 1.16% on the same day. Over the past week, Sichuan Kelun has seen a decrease of 4.54%, while its monthly performance remains positive at 26.99%. However, the company has faced challenges in its financial metrics, reporting negative results for the last six consecutive quarters. Key indicators include a net profit of CNY 1,141.6 million, reflecting a decline of 32.93%, and an operating cash flow of CNY 2,608.1 million, which is at its lowest point. Despite these recent struggles, Sichuan Kelun has shown strong long-term performance, with a year-to-date increase of 54.04% and a five-year growth of 151.87%. The company operates within the pharmaceuticals and biotechnology sector and holds a market capitalization of CNY 39,696 million.